1. Prolonged preservation of the blood-perfused canine heart with glycolysis-promoting solution 
Koh Takeuchi, MD, Hung Cao-Danh, PhD, Akihiko Kawai, MD, Akihiko Ohkado, MD, Hiroaki Konishi, MD, Francis X McGowan, MD, Pedro J del Nido, MD 
The Annals of Thoracic Surgery 
Volume 68, Issue 3, Pages (September 1999)
DOI: /S (99)

2. Fig 1
Peak developed pressure at a diastolic pressure of 15 mm Hg in control hearts (nonischemic) and after 2 hours of reperfusion in hearts subjected to 24 hours of 4°C ischemia receiving histidine-buffered solution (HBS) or University of Wisconsin solution (UWS). ∗p < 0.05 between HBS and UWS groups.
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

3. Fig 2
Peak systolic pressure at different balloon volumes in hearts subjected to 24 hours of 4°C ischemia receiving histidine-buffered solution (closed circles) or University of Wisconsin solution (open circles). Top, After 1 hour (left) and 2 hours (right) of reperfusion. Bottom, In the presence of low-dose (0.2 mg/L, left) or high-dose (1 mg/L, right) dobutamine in the perfusate. ∗p < 0.05 between groups.
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

4. Fig 3
End-diastolic pressure at different balloon volumes in hearts subjected to 24 hours of 4°C ischemia receiving histidine-buffered solution (closed circles) or University of Wisconsin solution (open circles). Top, After 1 hour (left) and 2 hours (right) of reperfusion. Bottom, In the presence of low-dose (0.2 mg/L, left) or high-dose (1 mg/L, right) dobutamine in the perfusate. ∗p < 0.05 between groups.
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

5. Fig 4
End-diastolic volume at a diastolic pressure of 15 mm Hg in control hearts (nonischemic) and hearts subjected to 24 hours of 4°C ischemia receiving histidine-buffered solution (HBS) or University of Wisconsin solution (UWS). There were no significant differences between control and HBS. ∗p < 0.05 between groups.
The Annals of Thoracic Surgery  , DOI: ( /S (99) )